AstraZeneca raises 2022 earnings outlook after Q3 results beat estimates By Investing.com
© Reuters By Scott Kanowsky Investing.com — AstraZeneca PLC (LON:) has raised its guidance for full-year income per share, citing strong returns in its third quarter, but warned that the outlook may face a larger […]
